Guanhao Biotech Co.,Ltd. (300238.SZ)

10.22 +0.31 (+3.13%) At close: 03:04PM CST

Guanhao Biotech Co.,Ltd.

No. 12 Yuyan Road
Huangpu District
Guangzhou 510530
China
86 20 3205 2806
https://www.guanhaobio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 535

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Yongming Zhang	Non-Independent Chairman & GM	N/A	N/A	1972
Mr. Weikun Zhang	Financial Manager	N/A	N/A	1986
Mr. Xu Qingrong	Deputy GM & Secretary	N/A	N/A	1981
Ms. Junhui Zhao	Deputy General Manager	N/A	N/A	1976
Mr. Feng Zhao	Deputy General Manager	N/A	N/A	1978
Mr. Zhen You	Deputy General Manager	N/A	N/A	1981
Mr. Huaixin Hou	Deputy General Manager	N/A	N/A	1968
Mr. Xianggui Lin	Deputy General Manager	N/A	N/A	1983

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicines and life sciences products in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. Its products can be used in neurosurgery, thoracic surgery, ophthalmology, dermatology, orthopedics, cosmetology, and other areas. The company was founded in 1999 and is headquartered in Guangzhou, China.

Corporate governance

Guanhao Biotech Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.